|
|
|
201-500 employees
View all
|
|
biotechnology
|
|
South San Francisco, California, US
|
|
Denali Therapeutics Inc. (“Denali”) is a biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, ALS and others. Denali was founded by scientists, industry experts and investors who share the vision that recent scientific insights into the genetic causes and biological processes underlying neurodegenerative disease, together with new translational medicine tools, offer an unprecedented opportunity to discover and develop effective medicines. Denali is rigorously pursuing a science-driven approach to translational medicine and clinical development. Founding investors include Fidelity Biosciences, ARCH Venture Partners, Flagship Ventures and the Alaska Permanent Fund (represented by Crestline Investors).
|
Denali Therapeutics Email Formats | Example Email Formats | Percentage |
---|---|---|
{last}.{first} | [email protected] |
35.65%
|
The widely used Denali Therapeutics email format is {last}.{first} (e.g. [email protected]) with 35.65% adoption across the company.
To contact Denali Therapeutics customer service number in your country click here to find.
Ryan Watts is the CEO of Denali Therapeutics. To contact Ryan Watts email at [email protected] or [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.